Drug intelligence / Profile preview

Trinity Elite Allograft

Development stage
Phase 3
Lead developer
Orthofix
Modality
Cell Therapies
Administration
Surgical Implantation
01

Overview

Trinity Elite Allograft is a third-generation cellular bone allograft (CBA) developed by Orthofix Medical and processed by MTF Biologics. It is designed as an alternative to autograft for bone grafting procedures, particularly in spinal fusion (cervical and lumbar) and foot and ankle arthrodesis. The product provides the three essential components for bone formation: an osteoconductive scaffold (cancellous bone matrix), osteoinductive potential (demineralized bone fibers containing growth factors like BMP-2), and osteogenic cells (viable mesenchymal stem cells, osteoprogenitor cells, and osteoblasts). It utilizes FiberLock technology for moldable handling without added carriers and is cryopreserved to maintain high cell viability (≥70%).

Brand names
Trinity Elite
Other names
Trinity Elite Cellular Bone Allograft

Beyond the preview

Go deeper on Trinity Elite Allograft.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trinity Elite Allograft.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call